Researchers are continually working to find new and better ways to manage and treat horses with pituitary pars intermedia dysfunction (PPID, formerly equine Cushing’s). Learn the most up-to-date informations about this disease from our experts.
About the Experts:
DVM, PhD, Dipl. ACVIM
Dianne McFarlane, DVM, PhD, Dipl. ACVIM, is an associate professor in physiological sciences at Oklahoma State University. Her research focuses on using a comparative animal approach to understanding the biological changes that accompany aging and the age-related factors that promote risk of neurodegenerative disease.
Marian G. Little
Marian G. Little, DVM, of Paris, Ky., is a field equine professional services veterinarian for Boehringer Ingelheim (BI). She joined BI in 2007 and is actively involved in pipeline projects, field studies, and conducting continuing education meetings for veterinarians. She currently serves as primary field technical support for Prascend, the only FDA-approved medication to control clinical signs of PPID. She also serves as a key BI liaison with Equine Endocrinology Group.